Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_assertion type Assertion NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_head.
- NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_assertion description "[The receptor tyrosine kinase MET is a prime target in clinical oncology due to its aberrant activation and involvement in the pathogenesis of a broad spectrum of malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_provenance.
- NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_assertion evidence source_evidence_literature NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_provenance.
- NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_assertion SIO_000772 24061647 NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_provenance.
- NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_assertion wasDerivedFrom befree-20150227 NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_provenance.
- NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_assertion wasGeneratedBy ECO_0000203 NP553862.RAGrma0t45RDENlFX_YMlLE57GTdUBJ8ZzaWs5Clipnuc130_provenance.